Previous 10 | Next 10 |
Shares of Avenue Therapeutics Inc. (NASDAQ:ATXI) traded at a new 52-week low today of $2.64. Approximately 996,000 shares have changed hands today, as compared to an average 30-day volume of 138,000 shares. Avenue Therapeutics Inc. has overhead space with shares priced $2.66, or 42.8% be...
Document Security Systems DSS -41% after secures $43.5M capital via equity raise.PDS Biotechnology PDSB -16% on proposing stock offering.Sage Therapeutics SAGE -12% after disappointing zuranolone secondary data in depression study.Vascular Biogenics VBLT -12...
peshkov/iStock via Getty Images Bitcoin (BTC-USD) received a boost on Monday thanks to comments from a couple of heavy hitters. Both Elon Musk and Paul Tudor Jones made remarks that goosed the cryptocurrency. Investors got some macro insight from a couple of top minds in the financial industr...
Gainers: Enochian Biosciences ENOB +127%, RAPT Therapeutics RAPT +101%, iTeos Therapeutics ITOS +37%, Novan NOVN +30%, Anavex Life Sciences AVXL +23%.Losers: Avenue Therapeutics ATXI -39%, Inhibikase Therapeutics (IKT) -21%, ...
Avenue Therapeutics ATXI -45% after FDA declines to approve IV tramadol pain medicine.Baosheng Media Group (BAOS) -16%.Lordstown Motors RIDE -13% as CEO and CFO exit following board probe.Fortress Biotech (FBIO) -13%.Orbsat(OSAT) -5%. For further details see: Lordsto...
Avenue Therapeutics (ATXI) shares slide more than 4% during premarket trading after the U.S. FDA declined to approve the company's New Drug Application (“NDA”) seeking approval for IV tramadol for the treatment of acute pain.The complete response letter ((CRL)) from th...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning and prepare yourself for another busy day of trading! We’re kicking off our coverage today with a look at the biggest pre-market stock movers for Wednesday. Source: ventdusud / Shutterstock.com B...
Mer Telemanagement Solutions (MTSL) -13%.Herman Miller (MLHR) -12% on acquiring Knoll for $1.8B.Lordstown Motors (RIDE) -9% after Endurance fails to finish Baja race.Globalstar (GSAT) -8%.Future FinTech Group (FTFT) -7% on announcing the closing of the acqui...
Gainers: Galectin Therapeutics (GALT) +17%, NexImmune (NEXI) +16%, Kymera Therapeutics (KYMR) +15%, Nurix Therapeutics (NRIX) +15%, DBV Technologies (DBVT) +13%.Losers: LifeMD (LFMD) -24%, CorMedix (CRMD) -11%, Cleveland BioLabs (CBLI) -9...
Shares of biopharmaceutical company Fortress Biotech (NASDAQ: FBIO) are dropping sharply on Tuesday after the company announced a regulatory update regarding one of its subsidiaries, Avenue Therapeutics (NASDAQ: ATXI) . As of 2:49 p.m. EDT, shares of Fortress Biotech were do...
News, Short Squeeze, Breakout and More Instantly...
Avenue Therapeutics Inc. Company Name:
ATXI Stock Symbol:
NASDAQ Market:
Avenue Therapeutics Inc. Website:
MIAMI, June 20, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced tha...
MIAMI, May 16, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced the ...
– Raised a total of $9.4 million in gross proceeds from warrant exercise transactions since January 2024 – MIAMI, May 15, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutica...